The association between human papillomavirus 16, 18 DNA load and E6 protein expression in cervical intraepithelial neoplasia and cancer

被引:6
|
作者
Wu, Zeni [1 ,2 ]
Yu, Lulu [1 ,2 ]
Lei, Xiaoqin [1 ,2 ,3 ]
Qin, Yu [1 ,2 ]
Zhang, Xun [2 ,4 ]
Chen, Wen [1 ,2 ]
Qiao, Youlin [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, Dept Canc Epidemiol, 17 South Panjiayuan Lane, Beijing 100021, Peoples R China
[2] Peking Union Med Coll, 17 South Panjiayuan Lane, Beijing 100021, Peoples R China
[3] Hubei Med Univ, Dongfeng Hosp, Dept Nutr, Shiyan 442000, Peoples R China
[4] Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, Dept Pathol, 17 South Panjiayuan Lane, Beijing 100021, Peoples R China
基金
中国国家自然科学基金;
关键词
Human papillomavirus; Viral load; E6; protein; Cervical cancer; Cervical intraepithelial neoplasia; VIRAL LOAD; RISK; ONCOPROTEIN;
D O I
10.1016/j.jcv.2018.08.008
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: It has been reported that high HPV DNA load and elevated E6 protein expression correlate with cervical cancer, but no epidemiological study has been performed. Objectives: To assess the association between type-specific HPV DNA load and presence of E6 protein in cervical intraepithelial neoplasia and cancer. Study design: This study was a cross-sectional multicenter study performed between 2013 and 2017. A total of 1717 women (normal histopathology: n = 916; CIN1: n = 94; CIN2: n = 63; CIN3: n = 130; SCC: n = 474; adenocarcinoma: n = 40) were included. HPV DNA load and presence of E6 protein were detected. DNA load was measured as log copies/10,000 cells. Results: The HPV16/18-E6 positivity rates increased from negative for DNA to the highest load grade. Compared to the HPV16 DNA negatives, women with low (RR = 31.5, 95% CI = 18.9-52.5), medium-low (RR = 133.5, 95% CI = 77.3-230.7), medium-high (RR = 247.9, 95% CI = 134.9-455.6) and high DNA loads (RR = 677.9, 95% CI = 301.6-1523.7) had increasingly higher relative ratios of HPV16-E6 expression. The association of HPV18-E6 with its DNA load was also significant for low (RR = 27.9, 95% CI = 10.4-74.9), medium-low (RR = 89.0, 95% CI = 32.8-241.3), medium-high (RR = 276.8, 95% CI = 76.7-998.9) and high grade (RR = 441.2, 95% CI = 97.7-1992.4). The positivity rates of both HPV16 DNA and E6 protein increased consistently with the severity of diseases from normal histopathology to SCC. Unlike HPV16, the trends of HPV18 DNA and E6 protein fluctuated consistently among women from normal histopathology to cancer. DNA load in E6-positive women was significantly higher than E6-negative for both types. Conclusions: There is a type-dependent association between HPV16/18 DNA load and E6 protein; our study furthers the understanding of the natural history of cervical cancer.
引用
收藏
页码:6 / 11
页数:6
相关论文
共 50 条
  • [21] Association between expression of human papillomavirus 16/18 E6 oncoprotein and survival in patients with stage I non-small cell lung cancer
    Hsu, Nan-Yung
    Cheng, Ya-Wen
    Chan, I-Ping
    Ho, Heng-Chien
    Chen, Chih-Yi
    Hsu, Chung-Ping
    Lin, Meng-Hung
    Chou, Ming-Chih
    ONCOLOGY REPORTS, 2009, 21 (01) : 81 - 87
  • [22] Hypermutation in the E2 gene of human papillomavirus type 16 in cervical intraepithelial neoplasia
    Kukimoto, Iwao
    Mori, Seiichiro
    Aoyama, Satoru
    Wakae, Kousho
    Muramatsu, Masamichi
    Kondo, Kazunari
    JOURNAL OF MEDICAL VIROLOGY, 2015, 87 (10) : 1754 - 1760
  • [23] E6-Associated Protein Is Required for Human Papillomavirus Type 16 E6 to Cause Cervical Cancer in Mice
    Shai, Anny
    Pitot, Henry C.
    Lambert, Paul F.
    CANCER RESEARCH, 2010, 70 (12) : 5064 - 5073
  • [24] Association of Human Papillomavirus L1 Capsid Protein with Koilocytosis, Expression of p16, and Ki-67, and Its Potential as a Prognostic Marker for Cervical Intraepithelial Neoplasia
    Chen, Lan
    Sun, Ming-jun
    Shi, Hong-yan
    He, Qing
    Liu, Dong-ge
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 2013, 35 (03): : 139 - 145
  • [25] DNA vaccine against human papillomavirus type 16: Modifications of the E6 oncogene
    Polakova, Ingrid
    Pokorna, Dana
    Duskova, Martina
    Smahel, Michal
    VACCINE, 2010, 28 (06) : 1506 - 1513
  • [26] Low-Cost Molecular Biomarker HPV-16/18 E6 Oncoprotein Expression in Cervical Intraepithelial Neoplasia (CIN) and Cervical Cancer with Its Relation with Severity of Neoplastic State
    Ara, Rifat
    Pervin, Shahana
    Khatun, Sabera
    Shahera, Umme
    Sultana, Masuda
    Aktar, Mst. Nurunnahar
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2020, 18 (03)
  • [27] Human papillomavirus type 16 E6 and E7 gene variations in Indian cervical cancer
    Pillai, MR
    Sreevidya, S
    Pollock, BH
    Jayaprakash, PG
    Herman, B
    GYNECOLOGIC ONCOLOGY, 2002, 87 (03) : 268 - 273
  • [28] Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy
    Pal, Asmita
    Kundu, Rita
    FRONTIERS IN MICROBIOLOGY, 2020, 10
  • [29] The E6 gene polymorphism of Human papillomavirus 16 in relation to the risk of cervical cancer in Tunisian women
    Rhouma, Rahima Bel Haj
    Ardhaoui, Monia
    Othman, Houcemeddine
    Ben Jemia, Zeineb
    El Abidine, Amira Zine
    Fehri, Emna
    Ouerheni, Kaouther
    Laassili, Thalja
    Tounsi, Haifa
    Guizani, Ikram
    Boubaker, Med Samir
    Ennaifer, Emna
    INFECTION GENETICS AND EVOLUTION, 2023, 116
  • [30] Human papilloma virus (HPV)-E6/E7 and epidermal growth factor receptor (EGF-R) protein levels in cervical cancer and cervical intraepithelial neoplasia (CIN)
    Mathur, SP
    Mathur, RS
    Rust, PF
    Young, RC
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2001, 46 (04): : 280 - 287